rs3765456

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001250.6(CD40):​c.646+28G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,612,390 control chromosomes in the GnomAD database, including 14,445 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1444 hom., cov: 29)
Exomes 𝑓: 0.12 ( 13001 hom. )

Consequence

CD40
NM_001250.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.143

Publications

13 publications found
Variant links:
Genes affected
CD40 (HGNC:11919): (CD40 molecule) This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]
CD40 Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 20-46128252-G-A is Benign according to our data. Variant chr20-46128252-G-A is described in ClinVar as Benign. ClinVar VariationId is 1267312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD40NM_001250.6 linkc.646+28G>A intron_variant Intron 7 of 8 ENST00000372285.8 NP_001241.1 P25942-1A0A0S2Z3C7Q6P2H9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD40ENST00000372285.8 linkc.646+28G>A intron_variant Intron 7 of 8 1 NM_001250.6 ENSP00000361359.3 P25942-1

Frequencies

GnomAD3 genomes
AF:
0.124
AC:
18670
AN:
150980
Hom.:
1447
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.166
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.0667
Gnomad EAS
AF:
0.418
Gnomad SAS
AF:
0.173
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.114
Gnomad OTH
AF:
0.119
GnomAD2 exomes
AF:
0.144
AC:
36089
AN:
251436
AF XY:
0.143
show subpopulations
Gnomad AFR exome
AF:
0.109
Gnomad AMR exome
AF:
0.119
Gnomad ASJ exome
AF:
0.0750
Gnomad EAS exome
AF:
0.438
Gnomad FIN exome
AF:
0.134
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.124
GnomAD4 exome
AF:
0.124
AC:
180592
AN:
1461312
Hom.:
13001
Cov.:
35
AF XY:
0.125
AC XY:
90613
AN XY:
726982
show subpopulations
African (AFR)
AF:
0.107
AC:
3591
AN:
33468
American (AMR)
AF:
0.118
AC:
5266
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0699
AC:
1826
AN:
26136
East Asian (EAS)
AF:
0.375
AC:
14894
AN:
39688
South Asian (SAS)
AF:
0.160
AC:
13763
AN:
86244
European-Finnish (FIN)
AF:
0.136
AC:
7242
AN:
53416
Middle Eastern (MID)
AF:
0.115
AC:
666
AN:
5768
European-Non Finnish (NFE)
AF:
0.113
AC:
125089
AN:
1111496
Other (OTH)
AF:
0.137
AC:
8255
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9113
18225
27338
36450
45563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4734
9468
14202
18936
23670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.124
AC:
18674
AN:
151078
Hom.:
1444
Cov.:
29
AF XY:
0.126
AC XY:
9276
AN XY:
73724
show subpopulations
African (AFR)
AF:
0.106
AC:
4368
AN:
41064
American (AMR)
AF:
0.115
AC:
1741
AN:
15184
Ashkenazi Jewish (ASJ)
AF:
0.0667
AC:
231
AN:
3464
East Asian (EAS)
AF:
0.418
AC:
2125
AN:
5084
South Asian (SAS)
AF:
0.173
AC:
825
AN:
4774
European-Finnish (FIN)
AF:
0.119
AC:
1233
AN:
10366
Middle Eastern (MID)
AF:
0.113
AC:
33
AN:
292
European-Non Finnish (NFE)
AF:
0.114
AC:
7721
AN:
67852
Other (OTH)
AF:
0.118
AC:
246
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
744
1488
2233
2977
3721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.111
Hom.:
190
Bravo
AF:
0.124
Asia WGS
AF:
0.234
AC:
810
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied by a panel of primary immunodeficiencies. Number of patients: 23. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.1
DANN
Benign
0.65
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3765456; hg19: chr20-44756891; COSMIC: COSV64847830; COSMIC: COSV64847830; API